doi: 10.1016/s0025-7125(16)36787-6.
Patient tolerance to interferon: clinical and laboratory assessments
- PMID: 2426535
- DOI: 10.1016/s0025-7125(16)36787-6
Item in Clipboard
Patient tolerance to interferon: clinical and laboratory assessments
Med Clin North Am.
1986 May.
Abstract
Toxicity has been associated with interferon therapy, predominantly in immunocompromised patients. Side effects appear to be dose-related and were difficult to manage. However, interferon was well-tolerated and some of the toxicity may be related to the immunocompromised state.
Similar articles
-
Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.Lancet. 1980 Jul 19;2(8186):113-8. doi: 10.1016/s0140-6736(80)90004-5. Lancet. 1980. PMID: 6157064
-
Pharmacokinetic and pharmacological aspects of interferon therapy in man.Acta Microbiol Acad Sci Hung. 1981;28(3):257-62. Acta Microbiol Acad Sci Hung. 1981. PMID: 6171139 Review. No abstract available.
-
[Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].Orv Hetil. 2006 Feb 19;147(7):321-4. Orv Hetil. 2006. PMID: 17489160 Hungarian.
-
Interferon therapy.NITA. 1987 Jan-Feb;10(1):40-2. NITA. 1987. PMID: 2434885 No abstract available.
-
Pharmacokinetics and side effects of interferon in man.Tex Rep Biol Med. 1977;35:541-7. Tex Rep Biol Med. 1977. PMID: 358475 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
